Volume 31, Issue 4 pp. 394-401
Original Article

The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study

Juria Nakano

Juria Nakano

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Fumihiko Urabe

Corresponding Author

Fumihiko Urabe

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Correspondence

Fumihiko Urabe M.D., Ph.D., Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Email: [email protected]

Search for more papers by this author
Yuria Kiuchi

Yuria Kiuchi

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan

Search for more papers by this author
Shigeyoshi Takamizawa

Shigeyoshi Takamizawa

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Hirotaka Suzuki

Hirotaka Suzuki

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Shota Kawano

Shota Kawano

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan

Search for more papers by this author
Keiichiro Miyajima

Keiichiro Miyajima

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Wataru Fukuokaya

Wataru Fukuokaya

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kazuhiro Takahashi

Kazuhiro Takahashi

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kosuke Iwatani

Kosuke Iwatani

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan

Search for more papers by this author
Yu Imai

Yu Imai

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Sotaro Kayano

Sotaro Kayano

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Koichi Aikawa

Koichi Aikawa

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Takafumi Yanagisawa

Takafumi Yanagisawa

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kojiro Tashiro

Kojiro Tashiro

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Jikei Katsushika Medical Center, Tokyo, Japan

Search for more papers by this author
Steffi Yuen

Steffi Yuen

Division of Urology, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

Search for more papers by this author
Shun Sato

Shun Sato

Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Shunsuke Tsuzuki

Shunsuke Tsuzuki

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Jun Miki

Jun Miki

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Department of Urology, Jikei University Kashiwa Hospital, Chiba, Japan

Search for more papers by this author
Takahiro Kimura

Takahiro Kimura

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
on behalf of JIKEI-YAYOI Collaborative Group

JIKEI-YAYOI Collaborative Group

Search for more papers by this author
First published: 27 December 2023
Citations: 8

Juria Nakano and Fumihiko Urabe contributed equally.

Abstract

Background

With the development of kidney-sparing surgery and neoadjuvant chemotherapy, ureteroscopic biopsy (URSBx) has become important for the management of upper tract urothelial carcinoma (UTUC).

Methods

We retrospectively analyzed data from 744 patients with UTUC who underwent radical nephroureterectomy (RNU), stratified into no ureteroscopy (URS), URS alone, and URSBx groups. Intravesical recurrence-free survival (IVRFS) was examined using the Kaplan–Meier method. We conducted Cox regression analyses to identify risk factors for IVR. We investigated differences between clinical and pathological staging to assess the ability to predict the pathological tumor stage and grade of RNU specimens.

Results

Kaplan–Meier curves and multivariate Cox regression revealed significantly more IVR and inferior IVRFS in patients who underwent URS and URSBx. Superficial, but not invasive, bladder cancer recurrence was more frequent in the URS and URSBx groups than in the no URS group. Clinical and pathological staging agreed for 55 (32.4%) patients. Downstaging occurred for 48 (28.2%) patients and clinical understaging occurred for 67 (39.4%) patients. Upstaging to muscle-invasive disease occurred for 39 (35.8%) of 109 patients with ≤cT1 disease. Clinical and pathological grading were similar for 72 (42.3%) patients. Downgrading occurred for 5 (2.9%) patients, and clinical undergrading occurred for 93 (54.7%) patients.

Conclusion

URS and URSBx instrumentation will be risk factors for superficial, but not invasive, bladder cancer recurrence. Clinical understaging/undergrading and upstaging to muscle-invasive disease occurred for a large proportion of patients with UTUC who underwent RNU. These data emphasize the challenges involved in accurate UTUC staging and grading.

CONFLICT OF INTEREST STATEMENT

The authors declare that they have no conflict of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.